Alrex
Company: Bausch & Lomb, PharmosApproval Status: Approved March 1998
Treatment for: seasonal allergic conjunctivitis
Areas: Eye Health / Ophthalmology
General Information
Alrex is indicated for the treatment of seasonal allergic conjunctivitis, an inflammation of the eye usually caused by pollens. Seasonal allergic conjunctivitis produces itching, tearing, redness, and swelling in the membrane that covers the inside of the eyelid and the white part of the eye.
Alrex Drug Information
The Alrex drug information shown above is licensed from Thomson CenterWatch. The information provided here is for general educational purposes only and does not constitute medical or pharmaceutical advice which should be sought from qualified medical and pharmaceutical advisers.
